REQUEST A DEMO
Total
USD $0.00
Search more companies

Homeopharma Bt. (Hungary)

Main Activities: Pharmacies and Drug Stores
Full name: HOMEOPHARMA Egeszsegugyi Szolgaltato Bt. Profile Updated: July 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Hungarian Download a sample report

Homeopharma Bt. is an enterprise based in Hungary. Its main office is in Budapest. The company operates in the Pharmacies and Drug Stores industry. Homeopharma Bt. was incorporated on June 24, 1999. It currently has a total number of 9 (2024) employees. In 2023, the company reported a net sales revenue increase of 7.61%. Its’ total assets recorded a growth of 8.39%. Homeopharma Bt.’s net profit margin decreased by 1.4% in 2023.

Headquarters
Hidegkuti ut 169.
Budapest; Budapest; Postal Code: 1028

Contact Details: Purchase the Homeopharma Bt. report to view the information.

Basic Information
Total Employees:
Purchase the Homeopharma Bt. report to view the information.
Outstanding Shares:
Purchase the Homeopharma Bt. report to view the information.
Registered Capital:
Purchase the Homeopharma Bt. report to view the information.
Incorporation Date:
June 24, 1999
Key Executives
Purchase this report to view the information.
Executive Officer
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Homeopharma Bt. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
7.61%
Total operating revenue
7.57%
Operating profit (EBIT)
-16.65%
EBITDA
-11.93%
Net Profit (Loss) for the Period
-19.42%
Total assets
8.39%
Total equity
22.56%
Operating Profit Margin (ROS)
-1.47%
Net Profit Margin
-1.4%
Return on Equity (ROE)
-16.06%
Quick Ratio
-0.16%
Cash Ratio
-0.17%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?